Overview of Key Findings About Future Uptake of a New Bundled Approach to PPH Detection and Management Across Data Sources and Countries
Kenya | Nigeria | South Africa | Tanzania | QES | |||||
---|---|---|---|---|---|---|---|---|---|
Interviews | Survey | Interviews | Survey | Interviews | Survey | Interviews | Survey | ||
PPH detection | |||||||||
Use of a new measurement tool such as the calibrated drape will require staff being trained in how to use it | Agree | Not found | Agree | Not found | Agree | Not found | Not found | Not found | Not found |
The new measurement tool (calibrated drape) can accurately measure blood loss which consequently could result in more PPH being detected | Agree | Not found | Agree | Not found | Agree | Not found | Not found | Not found | Not found |
Concerns about how the new measurement tool (calibrated drape) will fit in with current methods of collecting blood | Agree | Not found | Agree | Not found | Agree | Not found | Not found | Not found | Not found |
PPH treatment | |||||||||
All components of the care bundle are part of current PPH management except tranexamic acid which is not routinely administered | Agree | Partially Agree | Agree | Partially Agree | Agree | Partially Agree | Not found | Partially Agree | Not found |
Training on using tranexamic acid is required particularly for midwives who currently may not administer IV medications | Agree | Partially Agree | Agree | Agree | Agree | Disagree | Not found | Partially Agree | Not found |
Use of multiple interventions like in the PPH care bundle depends on having a large team available; one person cannot deliver the care bundle | Agree | Agree | Not found | Partially Agree | Agree | Partially Agree | Partially Agree | Partially Agree | Not found |
Future uptake of a care bundle could be effective at changing how PPH is currently treated for vaginal births | Agree | Partially Agree | Agree | Partially Agree | Agree | Partially Agree | Not found | Agree | Not found |
Overall use of a “bundled” approach to PPH treatment | |||||||||
Uptake of multiple interventions when treating PPH (e.g., MOTIVE bundle) will be challenging for staff to implement in the future | Disagree | Partially Agree | Disagree | Partially Agree | Disagree | Partially Agree | Not found | Partially Agree | Not found |
The uptake of MOTIVE bundle depends on the confidence of staff to deliver all components as a bundle, i.e., all at once or in quick succession | Not found | Not found | Partially Agree | Not found | Partially Agree | Not found | Not found | Not found | Not found |
Uptake of MOTIVE bundle relies on having sufficient staff on wards and having a reliable supply and consistent stock of the necessary drugs and equipment | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree | Agree |
The MOTIVE bundle to detect and treat PPH is likely to improve current management of vaginal births and reduce PPH-related mortality | Agree | Agree | Agree | Agree | Agree | Agree | Not found | Agree | Not found |
Abbreviations: MOTIVE, massage of uterus, oxytocic drugs administration, tranexamic acid administration, intravenous fluids administration, examination for identifying and managing the source of bleeding, and escalation to more advanced care, if bleeding continues despite treatment; PPH, postpartum hemorrhage; QES, qualitative evidence synthesis.